Ask the Experts

Ask the Experts

Ask the Experts


Rapid Initiation of HIV Care

How should treating clinicians approach risk-benefit discussions concerning the rapid initiation of antiretroviral therapy (ART) in treatment-naive patients with newly diagnosed HIV?



Biosimilars in Rheumatology

What are important differences in biosimilar vs innovator reference product manufacturing, development, and approval?



Multiple Sclerosis

What are the clinical roles for molecular biomarkers in diagnosing and monitoring MS disease progression and treatments response?



Hidradenitis suppurativa

How do you treat Hidradenitis suppurativa? Does this differ for patients with severe, recalcitrant Hidradenitis suppurativa?



Treatment-Resistant Depression

Why are high rates of partial or inadequate responses to first-line antidepressant therapy seen in patients with major depressive disorder (MDD)?